Pancreatic Cancer Research

ResearcherHokkaido UniversityActive in the last 2 years

Zenya Naito

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-9920-6296; OpenAlex author ID A5077576619, A5121453246. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: none · 2014: 3 papers · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 10

  1. Distance From the Root of the Splenic Artery to the Tumor as a Predictor of Para-Aortic Lymph Node Metastasis in Left-Sided Pancreatic Cancer. Co-author DOI 10.1002/jhbp.70074↗
  2. 2-Deoxy-d-glucose increases GFAT1 phosphorylation resulting in endoplasmic reticulum-related apoptosis via disruption of protein N-glycosylation in pancreatic … Last author DOI 10.1016/j.bbrc.2018.05.041↗
  3. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. Co-author DOI 10.3892/or.2016.4727↗
  4. Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice. Co-author DOI 10.1016/j.ajpath.2013.11.014↗
  5. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases. Co-author DOI 10.1038/onc.2013.392↗
  6. Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer. Co-author DOI 10.1111/cas.12470↗
  7. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation. Last author DOI 10.1016/j.ajpath.2012.01.020↗
  8. Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer. Last author DOI 10.1016/j.canlet.2012.01.023↗
  9. Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer. Co-author DOI 10.3892/ijo.2011.1280↗
  10. Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis. First author DOI 10.4161/cbt.11.5.14673↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshiyuki Ishiwata · 8 shared papers, 2011–2016 · strength 0.36
  2. Kotaro Kimura · 1 shared paper, 2026 · strength 0.29
  3. Satoshi Hirano · 1 shared paper, 2026 · strength 0.29
  4. Eiji Uchida · 5 shared papers, 2012–2016 · strength 0.24
  5. Yoko Matsuda · 4 shared papers, 2011–2016 · strength 0.20
  6. Murray Korc · 4 shared papers, 2011–2014 · strength 0.17
  7. Tetsushi Yamamoto · 3 shared papers, 2012–2018 · strength 0.15
  8. Junji Ueda · 3 shared papers, 2012–2014 · strength 0.13
  9. Hisashi Yoshimura · 2 shared papers, 2014 · strength 0.10
  10. Kousuke Ishino · 1 shared paper, 2018 · strength 0.07
  11. Hiroki Sumiyoshi · 1 shared paper, 2016 · strength 0.07
  12. Akira Matsushita · 1 shared paper, 2016 · strength 0.07
  13. Kazumitsu Cho · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.